Share Name Share Symbol Market Type Share ISIN Share Description
Glaxosmithkline Plc LSE:GSK London Ordinary Share GB0009252882 ORD 25P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  12.00 0.7% 1,718.80 1,718.60 1,719.00 1,720.00 1,704.80 1,718.80 698,751 09:54:06
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 30,821.0 4,048.0 73.7 23.3 85,329

Morphic Holding Sets IPO at 5 Million Shares; Sees Pricing at $14-$16 Apiece

14/06/2019 1:04pm

Dow Jones News

Glaxosmithkline (LSE:GSK)
Historical Stock Chart

6 Months : From Jun 2019 to Dec 2019

Click Here for more Glaxosmithkline Charts.

By Colin Kellaher


Morphic Holding Inc., a biopharmaceutical company backed by several large drug makers, on Friday said it will sell five million shares in its initial public offering, with an expected price range of $14 to $16 each.

At the $15 midpoint of that range, the Waltham, Mass., company said it expects net proceeds of about $67 million, or roughly $77.4 million if the underwriters exercise their option to buy an additional 750,000 shares.

Morphic said it will have about 29.3 million shares outstanding after the IPO and overallotment option, for a valuation of about $440.2 million at the $15 midpoint.

Morphic, which is working to develop oral small-molecule integrin therapeutics aimed at a range of diseases, said it has raised $248 million through equity financings and collaborations since its inception.

Biotech entrepreneur Timothy Springer, a co-founder of Morphic, will hold an 18.1% stake after the IPO, while GlaxoSmithKline PLC (GSK) will own 8%, Pfizer Inc. (PFE) will hold 7.7% and Novo Nordisk A/S (NVO) will own 6.9%, according to a filing with the Securities and Exchange Commission.

Morphic said it has applied to list its shares on the Nasdaq Global Market under the symbol MORF.


Write to Colin Kellaher at


(END) Dow Jones Newswires

June 14, 2019 07:49 ET (11:49 GMT)

Copyright (c) 2019 Dow Jones & Company, Inc.

1 Year Glaxosmithkline Chart

1 Year Glaxosmithkline Chart

1 Month Glaxosmithkline Chart

1 Month Glaxosmithkline Chart
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20191206 10:09:12